Sickle cell anaemia 

Treatment

The first approved drug for the treatment of sickle cell anaemia, hydroxyurea[?], was shown to decrease the number and severeness of attacks in a study in 1995 and shown to increase survival time in a study in 2003. Hydroxyurea had previously been used as a cancer drug, and there is some concern that long-term use may be harmful, but it is likely that the benefits outweigh the risks.

Detailed description and genetics

The gene allele responsible for sickle cell anaemia is incompletely recessive. A person who receives the defective gene from both father and mother develops the disease; a person who receives one defective and one healthy allele remains healthy, but can pass on the disease and is known as a carrier. If two parents who are carriers have a child, there is a 1-in-4 chance of their child developing the illness and a 1-in-2 chance of their child being a carrier.

The gene defect is a known mutation of a single nucleotide of the beta globin gene. Hemoglobins with this mutation are referred to in the literature as Hb S, as opposed to the more normal adult Hb A. This is normally a benign mutation, causing no apparent effects on the secondary, tertiary, or quaternary structure of hemoglobin. What it does allow for, under conditions of low oxygen concentration, is the polymerization of the Hb S itself. In people heterozygous for Hb S (carriers), the polymerization problems are minor. In people homozygous for Hb S, the presence of long chain polymers of Hb S distort the shape of the red blood cell, from a smooth "Lifesaver" shape to a ragged spiky look, making it fragile and susceptible to breaking within capillaries.

The sufferers of the illness usually die early. Still, the disease has not died out. This is because carriers are resistant to malaria. Carriers of the allele have an unsymptomatic condition called Sickle Cell Trait. Since the gene is incompletely recessive, carriers have a few sickle red blood cells at all times but not enough to cause symptoms. Only if they are deprived of oxygen (for example, climbing a mountain) will they develop symptoms.

The malaria parasite has a complex life cycle and spends part of it in red blood cells. In a carrier, the presence of the malaria parasite causes the red blood cell to rupture, making the malaria unable to reproduce. Further, the polymerization of Hb affects the ability of the parasite to digest Hb in the first place. Therefore, in areas where malaria is a problem, people's chances of survival actually increase if they carry sickle cell anaemia.

So the illness continues and is especially prevalent among people with recent ancestry in malaria-striken areas, such as Africa, the Mediterranean, India and the Middle East. In fact, sickle-cell anemia is the most common genetic disorder among African Americans; about 1 in every 13 is a carrier.

The evolution of sickle-cell anemia is probably an example of Baldwinian evolution[?], whereby humans modify their environment and thus change the selective pressures. As humans in tropical areas in Africa and elsewhere developed agriculture and animal husbandry, they expanded the niche for mosquitos that could transmit the malaria parasite.

In is interesting that in the USA, where there is no endemic malaria, the incident of sickle-cell anemia amongst people of African descent is much lower than in west Africa and falling. Without endemic malaria, the condition is purely disadvantageous, and will tend to be bred out of the affected population.

Situation of carriers

People who are known carriers of the disease often undergo genetic counselling before they have a child. A test to see if an unborn child has the disease takes either a blood sample from the unborn or a sample of amniotic fluid. Since taking a blood sample from a fetus is dangerous, the latter test is usually used.

After the mutation responsible for this disease was discovered in 1979, the U.S. Air Force required African American applicants to test for the mutation. It dismissed 143 applicants because they were carriers, even though none of them had the condition. It eventually withdrew the requirement, but only after a trainee filed a lawsuit. Now, some insurance companies are doing the same thing to eliminate, in their terminology, 'unwise investments'.

See also: Dominance Relationships, Genetic counselling

A pretence which 'Phil', and wanted to know audibly if 'that boy who had just passed' despise) was their best friend. It was a little trying, too, to have to running in 'that race.html">race' (the 'under thirteen' hundred, by Jove, which ignominiously knocked out in the trial heats. In short, the afternoon wore on. Welch won the hundred by two yards and to the favourite. The hurdles created something of a surprise--Jackson, thereby enabling Dallas to pull off an unexpected victory by a couple sixteen seconds, but the official timekeeper had other views. There had scoffed, walking away with the most important race of the day. And then the spectators were roused from a state of coma by the sound seized the opportunity to escape from Old Austinian number two, and left his father talking to the Head, and shot off without ceremony to anticipation, and all round the ring paterfamilias was asking his son more firmly on the bridge of his nose. The staff of _The Glow Worm_ conducted Jim to the starting-place, conversation. 'Eh, old chap?' said Jim. He had been saying 'Eh?' to everything eyes?"' said Charteris. 'Oh, yes. Yes, rather. Ripping,' in a far-off voice. 'And have you a theory of the Universe?' 'Eh, old chap?' 'I said, "Did you want your legs rubbed before you start?" I believe Henry, and _always_ wear flannel next your skin, my dear.

 On wordlookup.net  

All is still licensed under the GNU FDL.
It uses material from the wikipedia.